Background: Limited data are available regarding the effects of combined administration of L. and lime on weight loss and metabolic profiles among subjects with overweight subjects.

Objectives: The current study aimed to assess the effects of combined administration of L. and lime on weight loss and metabolic profiles among subjects with overweight.

Patients And Methods: This randomized double-blind placebo-controlled clinical trial was conducted on 72 subjects with overweight, aged 18 - 50 years old. Participants were randomly divided into three groups: Group A received high-dose L. and lime capsules (75 mg each, n = 24), group B low-dose L. and lime capsules (25 mg each, n = 24) and group C placebos (n = 24) twice daily for eight weeks.

Results: After eight weeks of intervention, compared with low-dose L. plus lime and placebo, taking high-dose L. plus lime resulted in significant weight loss (in the high-dose group: -2.1 ± 1.7 vs. in the low-dose group: -1.2 ± 1.5 and in the placebo group: + 0.2 ± 1.3 kg, respectively; P < 0.001) and body mass index (-0.8 ± 0.6 vs. -0.5 ± 0.5 and +0.1 ± 0.5 kg/m, respectively; P < 0.001). In addition, administration of high-dose L. plus lime compared with low-dose L. plus lime and placebo, led to a significant reduction in fasting plasma glucose (FPG) (P < 0.001) and a significant rise in quantitative insulin sensitivity check index (QUICKI) (+ 0.02 ± 0.02 vs. + 0.01 ± 0.02 and 0.01 ± 0.01, respectively; P = 0.01). Moreover, a significant decrease in serum triglycerides (-14.1 ± 56.2 vs. +13.9 ± 36.8 and + 10.6 ± 25.1 mg/dL; respectively; P = 0.03), total-cholesterol (-18.4 ± 28.6 vs. +8.6 ± 28.5 and -1.0 ± 24.8 mg/dL; respectively; P = 0.004) and low density lipoproteins- (LDL)-cholesterol levels (-11.8 ± 20.7 vs. +6.5 ± 23.2 and -2.9 ± 20.4 mg/dL, respectively; P = 0.01) was observed following the consumption of high-dose L. plus lime compared with low-dose L. plus lime and placebo.

Conclusions: Results of the current study indicated that taking high-dose L. plus lime for eight weeks among subjects with overweight had beneficial effects on weight, BMI, FPG, QUICKI, triglycerides, total-cholesterol and LDL-cholesterol levels.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065707PMC
http://dx.doi.org/10.5812/ircmj.34212DOI Listing

Publication Analysis

Top Keywords

high-dose lime
20
weight loss
16
low-dose lime
16
lime
12
loss metabolic
12
lime weight
12
subjects overweight
12
compared low-dose
12
randomized double-blind
8
double-blind placebo-controlled
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!